Femasys logo
Femasys
FEMY | NASDAQ
Chart Builder DCF Calculator
$1.28
-$0.14 (-9.86%)
At close: Nov 16, 2026, 4:00 PM ET
$1.30
+$0.02 (+1.56%)
After-hours: Nov 16, 2026, 7:30 PM ET

Femasys Company Profile

Company profile explained

Company Profile

Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering. For diagnostic purposes, Femasys provides FemCerv, a biopsy device utilized for endocervical curettage, and FemEMB, a product candidate intended for endometrial sampling to assist in the detection of uterine cancer. Additionally, the company markets its FemVue saline-air device across various international regions, including the U.S., Europe, Canada, and Japan. Its infertility-related products are supplied to obstetrician-gynecologists, other allied healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. The company also offers a range of non-surgical product technologies.

Key Executives

Name Position
Kathy Lee-Sepsick Founder, President, Chief Executive Officer & Director
Dov Elefant Chief Financial Officer
Jeremy Alexander Sipos Chief Technology Officer
John Canning Chief Operating Officer
James H. Liu Chief Medical Officer
Jeffrey Gerald Mifek Chief Clinical & Regulatory Affairs Officer

Latest SEC Filings

Date Type Title
Oct 15, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Sep 29, 2026 424B3 Filing
Sep 28, 2026 EFFECT Filing
Sep 03, 2026 S-3 Filing
Aug 31, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 20, 2026 D Filing
Aug 17, 2026 SC 13D Filing
Aug 14, 2026 10-Q Quarterly Report
Aug 14, 2026 8-K Current Report
Aug 14, 2026 SC 13G Statement of acquisition of beneficial ownership b...
View All SEC Filings ➞
Femasys
Femasys logo
Country United States
IPO Date Jun 18, 2021
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 53
CEO Kathy Lee-Sepsick

Contact Details

3950 Johns Creek Court Suwanee, Georgia 30024 United States

Stock Details

Ticker Symbol FEMY
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001339005
CUSIP Number 31447E204
ISIN Number US31447E2046
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.